In this multicenter study, we identified an increased risk of 30-day mortality among hospitalized children with carbapenem-resistant Enterobacteriaceae (CRE) isolated from clinical cultures compared with those with carbapenem-susceptible Enterobacteriaceae. We additionally report significant variation in antibiotic treatment for children with CRE infections with infrequent use of combination therapy.
- Gram-negative resistance
- Klebsiella pneumoniae carbapenemase
- Multidrug-resistant organism
ASJC Scopus subject areas
- Clinical Neurology